Lessee, Operating Lease, Liability, to be Paid in USD of POINT Biopharma Global Inc. from Q2 2023 to Q3 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's undiscounted obligation for lease payment for operating lease.
Summary: POINT Biopharma Global Inc. quarterly Lessee, Operating Lease, Liability, to be Paid history and change rate from Q2 2023 to Q3 2023.
POINT Biopharma Global Inc. Lessee, Operating Lease, Liability, to be Paid for the quarter ending 30 Sep 2023 was $7.97M.

Lessee, Operating Lease, Liability, to be Paid, Quarterly (USD)

POINT Biopharma Global Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2023	$7.97M			30 Sep 2023	10-Q	13 Nov 2023
Q2 2023	$445K			30 Jun 2023	10-Q	14 Aug 2023

* An asterisk sign (*) next to the value indicates that the value is likely invalid.